 |
|
Study examines novel PFO closure system
May 11, 2009A new device designed to close a common heart defect known as a patent foramen ovale (PFO) is safe and effective at 90-days follow up, according to a new study released today at the Society for Cardiovascular Angiography and Interventions (SCAI) 32nd Annual Scientific Sessions in Las Vegas.
PFO is a common condition in which a hole that connects the two upper chambers of the heart (atria) during fetal development fails to close properly after birth. About 25 percent of the general population has PFO, which is associated with an increased risk of stroke. PFO may also be associated with migraines and decompression illness in divers.
The FlatStent EF, developed by Coherex Medical,Inc., is unique because it is implanted within the PFO tunnel, leaving a minimal amount of the device exposed to circulation, which could reduce the risk of blood clots. The mechanism of action of the FlatStent EF should limit the incidence of other major complications associated with septal patching devices currently in use, such as erosion, persistent arrhythmia, and valve apparatus distortion.
In the study, 29 of 41 patients (70.7%) who received the FlatStent EF™ PFO Closure System had complete PFO closure immediately following implantation. After 90 days, 17 of 19 patients (89%) had complete or clinical closure. The remaining 22 patients had not yet completed the 90-day follow up exam.
"The FlatStent is designed to be safer and easier to use than current PFO closure systems," said Horst Sievert, MD, professor of internal medicine, cardiology and vascular medicine at the Cardiovascular Center in Frankfurt, Germany, and the study's principal investigator. "Given the number of patients living with PFO, the results of this study show promise in providing additional treatment options that could help prevent stroke and other conditions associated with PFO."
In the study, no device-related complications were reported. The 100-patient, multicenter registry study is designed to evaluate 30, 90 and 180-day safety and performance.
Society for Cardiovascular Angiography and Interventions
In the study, 29 of 41 patients (70.7%) who received the FlatStent EF™ PFO Closure System had complete PFO closure immediately following implantation. After 90 days, 17 of 19 patients (89%) had complete or clinical closure. The remaining 22 patients had not yet completed the 90-day follow up exam.
"The FlatStent is designed to be safer and easier to use than current PFO closure systems," said Horst Sievert, MD, professor of internal medicine, cardiology and vascular medicine at the Cardiovascular Center in Frankfurt, Germany, and the study's principal investigator. "Given the number of patients living with PFO, the results of this study show promise in providing additional treatment options that could help prevent stroke and other conditions associated with PFO."
In the study, no device-related complications were reported. The 100-patient, multicenter registry study is designed to evaluate 30, 90 and 180-day safety and performance.
Society for Cardiovascular Angiography and Interventions
Cardiovascular Angiography Current Events and Cardiovascular Angiography News RSSStudy finds African Americans at greater risk after PCI
A study from one of the largest public health systems in the country has found that African American patients experienced significantly worse outcomes after angioplasty and stenting than patients of other races, though researchers are not sure why.
Study shows benefits of anti-clotting medications reduced by common heartburn drugs
The anti-clotting action of the medication clopidogrel (Plavix) can be compromised by common drugs for the treatment of heartburn and ulcers resulting in a roughly 50% increase in the combined risk of hospitalization for heart attack, stroke and other serious cardiovascular illnesses.
Studies may show how to close the gap between women and men who suffer heart attacks
Age, condition and treatment delay are among the reasons women who undergo angioplasty for heart attack often do not fare as well as do men, according to two studies presented today at the Society for Cardiovascular Angiography and Interventions (SCAI) 32nd Annual Scientific Sessions.
SYNTAX defines borders between CABG and PCI with TAXUS drug-eluting stents
Coronary artery bypass grafting (CABG) should remain the "standard of care" for patients with complex coronary artery disease, concludes the SYNTAX study, published in the New England Journal of Medicine (online February 18, 2009, Print edition March 5).
New appropriate use criteria guide treatment of patients with heart blockage
If you're committed to fitness, the decision to climb a couple of flights of stairs rather than take the elevator is clear. But if you develop chest pain on the way up, deciding how to treat the symptoms of clogged arteries in your heart is much more complicated.
Stress tests to confirm need for cardiac stent not occurring in most patients, new study finds
UCSF researchers investigating the appropriate use of procedures to open narrowed coronary arteries -- such as angioplasty and stenting -- found that less than half of Medicare patients had documented noninvasive stress testing prior to elective percutaneous coronary intervention, or PCI, the clinical name for such procedures.
SAPPHIRE trial shows long-term benefit of carotid stenting as alternative to surgery
Carotid artery stenting is an effective option for high risk patients who are not eligible for surgery, according to a long-term study published in this week's New England Journal of Medicine. Carotid artery disease, which involves clogging of the arteries in the neck that provide blood to the brain, is a significant risk factor for stroke, making these study results important for the estimated 200,000 Americans each year who would otherwise not be candidates for the treatment.
Broad-based group of physicians calls for improvement in stroke treatment
A coalition of physicians representing a wide range of medical specialties has issued a call to action to improve the treatment of stroke.
SCAI highlights study using wireless technology to speed care of heart attack patients
Imagine paramedics mobilizing a team of cardiologists and nurses within minutes of arriving at the home of a person who is having a heart attack, simply by pressing a button that sends an electrocardiogram (ECG) over a wireless network.
Long-term anti-clotting therapy sweetens stenting outcomes in diabetic patients
A study showing that diabetic patients who are treated with long-term anti-clotting therapy are less likely to have a heart attack or die more than a year after stenting has been named among the best research papers presented at the 30th Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI), May 9-12, 2007.
More Cardiovascular Angiography Current Events and Cardiovascular Angiography News Articles
 |
Atlas of Non-Invasive Coronary Angiography by Multidetector Computed Tomography (Developments in Cardiovascular Medicine) by Guillem Pons-Llado (Editor), Ruben Leta-Petracca (Editor) The multidetector CT scanner speeds diagnosis and treatment of patients. One of its many uses is to perform CT coronary angiography. Multidetector CT has generated excitement within the cardiology and radiology community as it provides clear pictures and takes less time than other non-invasive techniques, including conventional spiral and electron-beam CT which can take up to an hour or more. This atlas presents over 160 illustrations, with 116 in color and illustrates the capacity of multidetector CT for the analysis of the anatomy of the coronary arteries. |
|
[Itm] 84" x 125" [Acsry To]: Proxima Femoral Angiography Drape - 84" x 125" by See description for detail. [Item]: 84" x 125" [Additional Info]: . Dual 5? (14 cm) circular fenestrations with incise and 3" (8cm) aperatures Absorbent reinforcement, 32" x 28" (81 x 71 cm) Catheter Pouch | |
 |
Understanding Cardiovascular Disease in Women Cardiovascular disease kills more American women than all forms of cancer combined, yet the perception remains that cardiovascular disease is a greater threat to men's health. This program focuses on the risks women face with cardiovascular disease, ways of reducing these risks, as well as new wide-ranging treatments for heart disease. Dr. Robert Robbins, MD, and Dr. Marcia Stefanick, Ph.D, deliver cutting-edge information on the state of research, the newest studies, and the latest treatments for cardiovascular disease in women. Dr. Robbins is the Director of the Stanford Institute for Cardiovascular Medicine. The Institute fosters and expands upon ongoing research, from the genetics and development of cardiovascular diseases to novel techniques for transplantation and restoring... |
|
Even low-risk patients may have plaque on CTA.(Cardiovascular Medicine)(computed tomographic angiography )(Clinical report): An article from: Internal Medicine News by Diana Mahoney (Author) This digital document is an article from Internal Medicine News, published by International Medical News Group on December 1, 2008. The length of the article is 600 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available immediately after purchase. You can view it with any web browser. Citation Details Title: Even low-risk patients may have plaque on CTA.(Cardiovascular Medicine)(computed tomographic angiography )(Clinical report) Author: Diana Mahoney Publication: Internal Medicine News (Magazine/Journal) Date: December 1, 2008 Publisher: International Medical News Group Volume: 41 Issue: 23 Page: 46(1) Article Type: Clinical report Distributed by Gale, a part of Cengage... | |
|
Coronary Angiography and P.T.C.A. [VHS] Starring: St Elizabeth Hospital and Medical Center | |
|
Advances in Noninvasive Cardiology: Ultrasound, Computed Tomography, Radioisotopes, Digital Angiography (Developments in Cardiovascular Medicine) by J. Meyer (Editor), P. Schweizer (Editor), R. Erbel (Editor) | |
|
Cardiovascular MRI: Angiography and Perfusion Studies with I Molar Gadolinium-Based Contrast Agent by Josef Vymazal (Editor) With its high resolution and non-invasive character, contrast-enhanced MR angiography (CE-MRA) is fast becoming a diagnostic method of choice in detecting cardiovascular disease. Additionally, MR scanners can also perform first-pass perfusion studies with contrast agents for the detection and characterization of tissue ischemia. This highly-illustrated text is based on the extensive experience with CE-MRA and perfusion studies by a team of Czech cardiologists and radiologists. They have chosen a practical rather than theoretical approach to apprize the reader of what they need to do when performing MR angiography or perfusion studies with high-concentration contrast agents. | |
|
Development of angiography and cardiovascular catheterization by T Doby (Author) | |
|
Coronary and Peripheral Angiography and Angioplasty (Current topics in cardiovascular medicine) by D.Richard Leachman (Author), Robert D. Leachman (Author), Denton A. Cooley (Foreword) This is a text on arteriographic studies in patients who have coronary artery disease. The text instructs the cardiologist in what he or she needs to know, how to perform angiography and angioplasty with reviews of various techniques and interpretations of their results. Angiography is the study of blood or lymph vessels by radiological means after the injection of an opaque contrast medium in to the vessel. Angioplasty is the plastic reconstruction of a diseased or injured blood vessel. The book should be of interest to cardiologists, cardiovascular surgeons, and scientists working in cardiovascular physiology. | |
![[Itm] Brachial Angiography Drape [Acsry To]: Proxima Brachial Angiography Drape -... see description](http://ecx.images-amazon.com/images/I/21S7P0BM2NL._SL160_.jpg) |
[Itm] Brachial Angiography Drape [Acsry To]: Proxima Brachial Angiography Drape -... see description by See description for detail. [Item]: Brachial Angiography Drape [Additional Info]: . 3 1/4" x 4 1/4" oval fenestration with incise |
| © 2009 BrightSurf.com |